Chemotherapy-free Treatment of Patients with BRAFV600E-mutant metastatic Colorectal Cancer

被引:0
|
作者
不详
机构
关键词
BRAF; VEMURAFENIB; INHIBITION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Chemotherapy-free Treatment of Patients with BRAFV600E mutated metastatic Colorectal Cancer
    Fabre, Pierre
    [J]. VISCERAL MEDICINE, 2020, 36 (03) : 251 - 251
  • [2] Improvements in Clinical Outcomes for BRAFV600E-Mutant Metastatic Colorectal Cancer
    Morris, Van K.
    Bekaii-Saab, Tanios
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (17) : 4435 - 4441
  • [3] Retrospective analysis of treatment pathways in patients with BRAFV600E-mutant metastatic colorectal carcinoma - MORSECRC
    Gerger, A.
    Eisterer, W.
    Fuxius, S.
    Bastian, S.
    Koeberle, D.
    Welslau, M.
    Akhoundova, D.
    Maas, C.
    Uhlig, J.
    Fenchel, K.
    Greil, R.
    von der Heyde, E.
    Agocs, Rhyner
    Weide, R.
    Modest, D. P.
    Fritsch, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 131 - 131
  • [4] Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC
    Gerger, Armin
    Eisterer, Wolfang
    Fuxius, Stefan
    Bastian, Sara
    Koeberle, Dieter
    Welslau, Manfred
    Sanoyan, Dilara Akhoundova
    Maas, Christian
    Uhlig, Jens
    Fenchel, Klaus
    Greil, Richard
    von der Heyde, Eyck
    Agocs, Gaelle Rhyner
    Weide, Rudolf
    Schwager, Monika
    Reichenbach, Frank
    Modest, Dominik Paul
    Fritsch, Ralph
    [J]. ANTICANCER RESEARCH, 2022, 42 (10) : 4773 - 4785
  • [5] Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting
    M. Zurloh
    M. Goetz
    T. Herold
    J. Treckmann
    P. Markus
    B. Schumacher
    D. Albers
    A. Rink
    V. Rosery
    G. Zaun
    K. Kostbade
    M. Pogorzelski
    S. Ting
    H. Schmidt
    R. Stiens
    M. Wiesweg
    M. Schuler
    Stefan Kasper
    I. Virchow
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 12903 - 12912
  • [6] European expert panel consensus on the clinical management of BRAFV600E-mutant metastatic colorectal cancer
    Martinelli, Erika
    Arnold, Dirk
    Cervantes, Andres
    Stintzing, Sebastian
    Van Cutsem, Eric
    Tabernero, Josep
    Taieb, Julien
    Wasan, Harpreet
    Ciardiello, Fortunato
    [J]. CANCER TREATMENT REVIEWS, 2023, 115
  • [7] First line treatment patterns in BRAFV600E-mutant metastatic colorectal cancer patients (mCRC): The CAPSTAN European retrospective study
    Asselain, B.
    Martinelli, E.
    Cremolini, C.
    Mazard, T.
    Vidal, J.
    Virchow, I.
    Tougeron, D.
    Castagne, C.
    Zkik, A.
    Khan, S.
    Arnold, D.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S553 - S553
  • [8] Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting
    Zurloh, M.
    Goetz, M.
    Herold, T.
    Treckmann, J.
    Markus, P.
    Schumacher, B.
    Albers, D.
    Rink, A.
    Rosery, V.
    Zaun, G.
    Kostbade, K.
    Pogorzelski, M.
    Ting, S.
    Schmidt, H.
    Stiens, R.
    Wiesweg, M.
    Schuler, M.
    Kasper, Stefan
    Virchow, I.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 12903 - 12912
  • [9] BRAFV600E-Mutant V600E-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities
    Piercey, Oliver
    Tie, Jeanne
    Hollande, Frederic
    Wong, Hui-Li
    Mariadason, John
    Desai, Jayesh
    [J]. CLINICAL COLORECTAL CANCER, 2024, 23 (03) : 215 - 229
  • [10] Baseline characteristics of patients enrolled in the CAPSTAN study: A European retrospective study in BRAFV600E-mutant metastatic colorectal cancer patients
    Martinelli, E.
    Asselain, B.
    Cremolini, C.
    Mazard, T.
    Vidal, J.
    Virchow, I.
    Tougeron, D.
    Berradi, H.
    Castagne, C.
    Arnold, D.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S113 - S113